europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Newsletter
    • Library
Become a member
✕

#EFIB2022:  Industrial biotechnology community comes together in Vilnius next week

19/10/2022
PRESS RELEASE

PRESS RELEASE

Brussels, 19 October 2022 

Leading industry leaders, SMEs representatives, start-ups, policy makers and academia are expected in Vilnius on 26-27 October, 2022 to join the 15th European Forum for Industrial Biotechnology and the Bioeconomy (EFIB). The annual event, hosted by EuropaBio, welcomes almost 300 participants to join discussions around next generation economies and how industrial biotechnology can contribute to a more sustainable society.

This year’s agenda amongst almost 60 speakers who will join the Conference in person and online, will feature Thierry Breton, European Commissioner for Internal Market, Virginijus Sinkevičius, European Commissioner for Environment, Oceans and Fisheries, prof. Virginijus Šikšnys, Vilnius university, and representatives from companies such as Solvay, DSM, LanzaTech, Ev Biotech and others.

‘EuropaBio is delighted to be hosting this year’s forum in Vilnius, with delegates joining us from across Europe. The theme ‘Next generation economies: Industrial biotechnology for a sustainable society comes at a critical time for Europe, as we experience a generational point of transition. Now is the time for the bioeconomy to achieve its full potential, driven by Europe’s powerful science base, inspirational SMEs, long term strategies in global companies and changes in consumer demand.’, says Dr Claire Skentelbery, Director General of EuropaBio.

EFIB participants will also have the chance to meet with 14 local and international start-ups, learn about recent projects in the industrial biotechnology field at the dedicated poster presentation area and set up business meetings via EFIB Partnering tool. EuropaBio’s Executive Roundtable will bring together members and invited guests for a discussion on key recommendations to deliver a competitive bioeconomy, developed for the EFIB Vilnius Statement.

#EFIB2022: Industrial biotechnology community comes together in Vilnius next week


Download
Share
Alexandra Simionca
Alexandra Simionca

Related posts

16/03/2023

Vision, clarity and enabling – the drivers for Europe’s biomanufacturing future


Read more
07/03/2023

Disc Medicine joins EuropaBio: life-changing medicines for patients with hematologic disorders


Read more
06/03/2023

Can the Pharmaceutical Strategy Deliver for Europe?


Read more
03/03/2023

For The Love of Science


Read more

Important links

  • Unlocking the Potential of Biotechnology Innovation for Patients
  • Vision, clarity and enabling – the drivers for Europe’s biomanufacturing future

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member